Due to recent regulatory restrictions in China and intensified enforcement actions affecting pharmaceutical raw material manufacturers, the global pharmaceutical industry is currently experiencing significant difficulties in sourcing pharmaceutical-grade ingredients for hormone-based formulations.
As a result, stock levels of many hormone-related products have been depleted worldwide, while new raw material batches remain limited or unavailable across multiple markets.
Integra Pharmaceuticals is actively working to stabilize its supply chain by qualifying alternative suppliers and transitioning procurement to verified manufacturing facilities that comply with our internal quality, safety, and documentation standards.
At the present time, the following product categories remain available in full volume:
- Vitamin-based injectable and supportive formulations
- Testosterone Propionate preparations
In addition, limited quantities of the following products are currently being received in small and irregular batches:
- Testosterone Enanthate
- Testosterone Cypionate
- Trenbolone Acetate
More specialized and less commonly produced compounds, including Drostanolone (Masteron), Methenolone (Primobolan), and other advanced anabolic formulations, are currently subject to severe global shortages and are not being manufactured at scale.
We continue to work toward restoring availability of these products. Any confirmed updates regarding new raw material batches or resumed production will be communicated through our Batch & Product Updates news section.